Coiled-coil-helix-coiled-coil-helix domain containing 4 pseudogene 5 (CHCHD4P5)

CHCHD4P5 (Coiled-coil-helix-coiled-coil-helix domain containing 4 pseudogene 5) is classified as a processed pseudogene, i.e., a noncoding genomic element derived by reverse transcription of the CHCHD4 gene transcript and insertion into a new genomic location. Pseudogenes like CHCHD4P5 do not encode functional proteins due to accumulated mutations that disrupt gene expression or translation. Recent studies indicate some pseudogenes may perform regulatory roles—such as through RNA-mediated gene expression modulation of their parental or related genes. However, for CHCHD4P5 specifically, there is no evidence of protein coding, therapeutic targeting, or disease association. As a pseudogene, it is not considered a therapeutic target, receptor, enzyme, or druggable protein. CHCHD4P5 is recognized by genomic databases as a pseudogene (HGNC locus type: pseudogene). The gene was derived as a retrocopy of the protein-coding gene CHCHD4, but itself is "processed" and likely nonfunctional at the protein level. Current databases list no interactions with drugs, no known relevant biomarkers, and no described mechanism of action. It is not a target in the context of drug development or biological receptor/enzymatic function. Pseudogenes can in some instances regulate parent gene expression or participate in gene networks via non-coding RNA transcripts, but such functions are not specific to CHCHD4P5. No evidence links CHCHD4P5 to any disease or directly to a biological function in health or pathology. CHCHD4P5 is a processed pseudogene that does not code for a functional protein and is not regarded as a therapeutic target, receptor, or enzyme. Its only recognized names are its full description and abbreviation. No information supports involvement in disease, drug interaction, or use as a biomarker.

Other names

CHCHD4P5